# Citations for Research Query

**Query:** # Mechanistic Hypothesis Search

You are evaluating a specific disease mechanism hypothesis for the Disorder
Mechanisms Knowledge Base. This is not a general disease overview. Use the
hypothesis YAML below as the seed claim, then search for evidence that supports,
refutes, qualifies, or competes with this hypothesis.

## Target Disease
- **Disease Name:** Deregulated Nutrient Sensing Module
- **Category:** Module

## Target Hypothesis
- **Hypothesis ID:** rapamycin_distinct_from_dietary_restriction
- **Hypothesis Label:** Rapamycin Extends Lifespan by a Route Distinct from Dietary Restriction
- **Status in KB:** EMERGING

## Seed Hypothesis YAML

```yaml
hypothesis_group_id: rapamycin_distinct_from_dietary_restriction
hypothesis_label: Rapamycin Extends Lifespan by a Route Distinct from Dietary Restriction
status: EMERGING
description: Rapamycin is routinely described as a dietary-restriction mimetic, on the reasoning that
  both down-shift anabolic nutrient signaling and both extend lifespan. This hypothesis holds that the
  shared endpoint conceals distinct routes - that pharmacologic mTORC1 inhibition and dietary restriction
  produce materially different endocrine, metabolic and hepatic transcriptional states, and therefore
  converge on longevity without being the same intervention. The distinction matters for this module because
  it determines whether mTORC1 hyperactivation is the single hub through which the whole hallmark acts,
  or one of several partly independent routes to the same consequence node.
evidence:
- reference: PMID:24341993
  supports: SUPPORT
  evidence_source: MODEL_ORGANISM
  snippet: Some of the endocrine and metabolic changes seen in diet-restricted mice are not seen in mice
    exposed to rapamycin, and the pattern of expression of hepatic genes involved in xenobiotic metabolism
    is also quite distinct in rapamycin-treated and diet-restricted mice, suggesting that these two interventions
    for extending mouse lifespan differ in many respects.
  explanation: 'Molecular rather than inferential separation of the two interventions: endocrine and metabolic
    changes diverge, and hepatic xenobiotic-metabolism expression is distinct. This is the primary evidence
    the hypothesis rests on.'
notes: The module currently takes no position on this question - the mTORC1 node describes rapamycin as
  targeting the anabolic hub without asserting equivalence to dietary restriction, and the AMPK node cites
  a review that groups caloric restriction, sirtuin activation and rapamycin together as one longevity-promoting
  arm. Those two framings are in mild tension and this hypothesis names it. A single study comparing two
  interventions in one tissue is thin support for a claim this load-bearing; the hypothesis is declared
  EMERGING to mark it as open rather than resolved.
```

## Research Objective

Build a focused hypothesis-search report that answers:

1. What is the strongest direct evidence for this hypothesis?
2. What evidence argues against it, fails to reproduce it, or limits its scope?
3. Which claims are established, emerging, speculative, or contradicted?
4. Which patient subtypes, stages, tissues, cell types, molecular pathways, or
   biomarkers does the hypothesis best explain?
5. Which alternative or competing mechanistic hypotheses explain the same disease
   features better or more parsimoniously?
6. What are the explicit knowledge gaps: missing causal steps, unconfirmed edges,
   contradictory evidence, unknown source-to-target links, or source/data absences?
7. What experiments, cohorts, assays, datasets, or trials would most directly
   distinguish this hypothesis from alternatives?

Use primary literature whenever possible. Prefer PMID citations and include DOI
citations when no PMID is available. Treat reviews as orientation unless they
contain directly relevant synthesized evidence that should be clearly labeled as
review-level support.

## Required Output

### Executive Judgment

Give a concise verdict on the hypothesis as of the current literature:
supported, partially supported, unresolved, weakly supported, or refuted. Explain
the reasoning and the most important caveats.

### Evidence Matrix

Create a table with one row per important evidence item:

- Citation (PMID preferred)
- Evidence type (human clinical, model organism, in vitro, computational, review)
- Supports / refutes / qualifies / competing
- Mechanistic claim tested
- Key finding
- Disease subtype or context
- Confidence and limitations

### Mechanistic Causal Chain

Describe the causal chain implied by the hypothesis from upstream trigger to
clinical manifestation. Identify where the literature is strong, where the links
are inferred, and where there are missing causal steps.

### Knowledge Gaps

Identify explicit known unknowns surfaced by the search. Treat absence of
evidence as a curation-relevant finding only when the search actually checked for
it. Include:

- Unknown or weakly supported causal steps in the hypothesis
- Unconfirmed causal graph edges that need direct perturbation or longitudinal
  evidence
- Conflicting evidence, failed replications, or incompatible subtype-specific
  findings
- Unknown mechanism of action for relevant treatments, biomarkers, or
  interventions tied to this hypothesis
- Source-level or dataset-level absences, such as no relevant GenCC, ClinGen,
  trial, omics, or cohort evidence found as of the search date

For each gap, state the scope, why it matters, what was checked, and what
evidence or experiment would resolve it.

### Alternative Models

List competing or complementary hypotheses. For each, explain whether it is an
alternative to the seed hypothesis, a downstream consequence, an upstream cause,
or a parallel mechanism.

### Discriminating Tests

Recommend concrete studies or assays that would most efficiently test this
hypothesis against alternatives. Include patient stratification, biomarkers,
sample type, model system, perturbation, and expected result where applicable.

### Curation Leads

Provide candidate updates for the KB, but label these as leads requiring curator
verification. Include:

- candidate evidence references and exact abstract snippets to verify
- candidate pathophysiology nodes or edges
- candidate ontology terms for cell types and biological processes
- candidate subtype restrictions or status changes
- candidate `knowledge_gaps` or discussion prompts for unresolved causal claims,
  conflicting evidence, or explicit source/data absences

If the provider supports artifacts, produce artifact-friendly outputs such as an
evidence matrix, mechanistic diagram, knowledge-gap table, or comparison table.
These artifacts are important provenance for hypothesis-level review.

**Provider:** openscientist
**Generated:** 2026-08-07T04:36:12.919399

1. PMID:20074526
2. PMID:31577953
3. PMID:23881200
4. PMID:25807975
5. PMID:21130151
6. PMID:30462643
7. PMID:24341993
8. PMID:30854544